The BCL-2-specific BH3-mimetic ABT-199 (GDC-0199) is active and well-tolerated in patients with relapsed non-Hodgkin lymphoma: Interim results of a phase I study Meeting Abstract
| Authors: | Davids, M. S.; Roberts, A. W.; Anderson, M. A.; Pagel, J. M.; Kahl, B. S.; Gerecitano, J. F.; Darden, D. E.; Nolan, C. E.; Gressick, L. A.; Yang, J. N.; Chyla, B. J.; Busman, T. A.; Graham, A. M.; Cerri, E.; Enschede, S. H.; Humerickhouse, R. A.; Seymour, J. F. |
| Abstract Title: | The BCL-2-specific BH3-mimetic ABT-199 (GDC-0199) is active and well-tolerated in patients with relapsed non-Hodgkin lymphoma: Interim results of a phase I study |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000313838902156 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V120.21.304.304 |
| Notes: | --- - Meeting Abstract: 304 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
